Maria J. Tellez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: January 25, 2024
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Journal: HIV medicine
Published: October 01, 2021
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 18, 2020
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: January 09, 2020
Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success.
Journal: World journal of urology
Published: November 15, 2019
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.
Journal: The Journal of infection
Published: May 25, 2019
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
Journal: AIDS (London, England)
Published: March 05, 2019
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1.
Journal: Open forum infectious diseases
Published: January 23, 2019
Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study.
Journal: AIDS patient care and STDs
Published: April 06, 2018
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings.
Journal: Hepatology (Baltimore, Md.)
Published: October 03, 2017
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.
Journal: Open forum infectious diseases
Published: September 05, 2017
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 17, 2017
Last Updated: 09/26/2026